Ketamine-Assisted Psychotherapy: A Comprehensive Guide to Treatment Options, Routes of Administration, and What to Expect
Meta Description: A thorough exploration of ketamine-assisted psychotherapy, including IV, intramuscular, sublingual, and intranasal routes of administration, dosing protocols, safety considerations, and how therapy integrates with treatment.
Keywords: ketamine-assisted psychotherapy, KAP, ketamine therapy, IV ketamine, ketamine infusion, ketamine for depression, ketamine treatment, ketamine routes of administration, sublingual ketamine, intramuscular ketamine
Introduction: Understanding Your Ketamine Treatment Options
Ketamine has emerged as one of the most promising treatments for depression, anxiety, PTSD, and other mental health conditions that haven't responded to conventional approaches. Unlike other psychedelic-assisted therapies still working through FDA approval, ketamine is already legally available through licensed medical providers, making it accessible to patients now.
However, ketamine treatment isn't one-size-fits-all. Multiple routes of administration exist, each with different characteristics, intensities, and applications for therapy. Understanding these options helps patients make informed decisions and helps therapists know what to expect when supporting clients through ketamine experiences.
The Three-Person Relationship
Before diving into specifics, it's crucial to understand how ketamine-assisted psychotherapy works as a collaborative model. As Dr. Meghan Oxley, an emergency medicine physician who co-founded an integrative ketamine clinic, explains: "The relationship with ketamine in the patient is always three people: it's the patient, the therapist, and the provider."
This triad matters because therapists don't make medical decisions about ketamine—that requires medical training and licensure. But therapists do need to understand enough about ketamine's medical aspects to assess whether clients might be appropriate candidates and to support them effectively during and after treatment.
How Ketamine Works: Core Mechanisms
Understanding ketamine's mechanism of action helps explain why different routes of administration create different experiences.
Ketamine primarily works by blocking NMDA glutamate receptors in the brain. This has several therapeutic effects. First, it promotes neuroplasticity—the brain's ability to form new connections. In depression, there's typically a loss of synaptic connections; ketamine helps reverse this by stimulating BDNF (brain-derived neurotrophic factor) and encouraging new neuronal growth.
Second, ketamine quiets the default mode network, the brain system associated with self-referential thinking and rumination. As Dr. Oxley describes it: "Their thoughts are like really woven together very tightly, and ketamine kind of relaxes that tightness of the thought. And now, as a therapist, you're trying to help them weave a new way of thinking, a new narrative—and there's a lot of room to get the threads in."
This combination of neuroplasticity and loosened cognitive patterns creates a window of opportunity for therapeutic work that's otherwise difficult to access.
Routes of Administration: An Overview
Ketamine can be administered through several routes, each creating a different profile of intensity, duration, and experience:
IV (Intravenous): Administered through a drip over 40-60 minutes. Most studied route with the most robust scientific literature. Gradual onset allows for dose adjustments during session.
IM (Intramuscular): Injection into muscle. Faster onset, more intense peak, easier to administer but less controllable once given.
Sublingual/Oral: Dissolves under tongue or swallowed. Lower bioavailability, milder experience, longer duration. Most accessible and lowest-risk option.
Intranasal: Sprayed into nose. Includes FDA-approved esketamine (Spravato) and compounded ketamine sprays. Moderate intensity.
The intensity of any route can be modulated by dose—you can make IV as intense as IM by increasing the dose, or make IM milder by using less. However, each route has characteristic patterns that shape the therapeutic experience.
IV Ketamine: The Gold Standard for Medical Treatment
IV ketamine is the most thoroughly researched route, with hundreds of published studies. The standard protocol typically involves six to eight infusions over three to four weeks, followed by maintenance boosters every four to six weeks.
A standard dose ranges from 0.5 mg/kg to 1.2 mg/kg delivered over 40-60 minutes. Interestingly, as Dr. Oxley notes, this protocol wasn't derived through rigorous comparative research but was borrowed from electroconvulsive therapy (ECT) scheduling. "They just modeled the infusion series after ECT... That protocol is helpful but it wasn't scientifically studied to the tee."
This means there's flexibility. Many patients do well with once-weekly infusions rather than more aggressive scheduling.
Advantages of IV: The gradual onset over 40-60 minutes allows providers to adjust—they can turn the drip up, down, or off entirely based on how the patient is responding. This makes IV particularly suitable for patients with histories of difficult psychedelic experiences, significant PTSD where they might "get into the woods," or high sensitivity to medications where finding the right dose requires titration.
What the experience is like: Patients start to feel effects within a few minutes as the drip begins, building gradually to peak and then clearing within two to three minutes after the infusion stops. The experience can range from mild (like "one glass of wine") to profound cosmic experiences, even at the same dose in different people. This variability is characteristic of ketamine.
Intramuscular (IM) Ketamine: For Deeper Psychotherapeutic Work
Intramuscular ketamine is often the choice for ketamine-assisted psychotherapy (KAP) because it creates a longer, more immersive experience conducive to deep therapeutic work. Sessions typically last around three hours.
Key characteristics: IM ketamine produces a faster onset and more intense peak than IV. The patient receives the entire dose at once (unlike the gradual IV drip), which creates a more defined "journey" with clearer beginning, middle, and end.
Scientific literature on IM ketamine for mental health is more limited—Dr. Oxley notes only five published studies using doses ranging from 0.5 to 2 mg/kg.
Important safety consideration: "IM ketamine is actually in many ways less safe than IV ketamine," Dr. Oxley emphasizes, "because the patient's getting all of the dose at once instead of over an hour, and then you can't take it back. With IV, you can turn it off... with IM ketamine, you're in it until they're done."
Higher doses (above 1 mg/kg) should be administered in settings with resuscitation capability and personnel trained in ACLS (Advanced Cardiac Life Support). Lower doses (0.5 mg/kg) carry significantly less risk.
Therapist considerations: IM sessions are emotionally demanding for therapists as well. Many practices limit therapists to one KAP session per day, supplemented by traditional therapy hours. "Our therapists have a hard time doing two IM sessions in one day. They find it to be emotionally quite exhausting."
Sublingual and Oral Ketamine: Accessibility and Safety
Sublingual ketamine—where the medication dissolves under the tongue—represents the most accessible and lowest-risk option. It comes in several forms: troches (small lozenges the consistency of a Skittle), rapid-dissolving tablets (RDTs, like Smarties candy), or liquid that can be held in the mouth.
Key characteristics: Bioavailability is significantly reduced with sublingual/oral administration because much of the ketamine is metabolized by the liver before reaching the brain. This creates milder, shorter experiences with a gentler onset curve.
As Dr. Oxley notes: "Sublingual ketamine is very cheap, very easy, has a nice dosing curve, has a very low likelihood of adverse outcomes because the medicine concentration does not peak rapidly like it does with IM, which is one of the problems—that really rapid onset is why you run into safety issues."
Therapeutic applications: Sublingual ketamine can be useful for:
Patients beginning ketamine treatment who need gentler introduction
At-home maintenance between clinic sessions
Patients who want support for therapy but don't need or want intense psychedelic experiences
Cost-conscious treatment (compounded sublingual ketamine is typically much less expensive than IV)
Intranasal Ketamine: Including Esketamine (Spravato)
Intranasal ketamine falls between sublingual and IM in intensity. This includes FDA-approved esketamine (Spravato)—the S-enantiomer of ketamine—which is administered in certified healthcare settings.
Compounded intranasal ketamine (using racemic ketamine) is also used in some practices. The experience profile is relatively short, similar to or slightly more intense than sublingual.
What Happens During a Ketamine Session
Regardless of route, ketamine produces altered states of consciousness that can include:
Physical effects: Patients often feel "heavy" or disconnected from their body. Coordination is impaired, which is why patients should not drive for several hours after treatment. Some experience nausea, though this is typically manageable.
Perceptual changes: Visual and auditory perception may shift. Some patients report geometric patterns, enhanced colors, or a dream-like quality to their experience.
Dissociation: Ketamine can produce a sense of separation from ordinary experience—feeling like an observer of one's own thoughts, emotions, or memories. This can facilitate therapeutic processing by allowing difficult material to be approached with less overwhelming intensity.
Transpersonal experiences: At higher doses, some patients report experiences of ego dissolution, interconnection, or spiritual significance similar to those seen with classical psychedelics.
The specific content and quality of ketamine experiences varies enormously between individuals and even between sessions in the same individual.
The Therapeutic Frame: How Psychotherapy Integrates
What distinguishes ketamine-assisted psychotherapy from medical ketamine treatment is the intentional integration of psychotherapy throughout the process.
Preparation sessions establish therapeutic rapport, assess the patient's history and goals, and prepare them for what to expect. The therapist helps the patient develop intentions for their ketamine work.
During the session, a therapist remains present to provide support, offer reassurance if difficult material emerges, and witness the experience. The therapist follows the patient's process rather than directing it.
Integration sessions afterward help patients make meaning of their experiences, connect insights to their lives, and translate acute experiences into lasting change.
As Dr. Veronika Gold notes, some patients who don't respond to IV ketamine alone do respond when psychotherapy is added, "because some of the patients who did not respond to the IV treatment maybe respond to the psychotherapeutic process and processing some of the underlying issues."
Choosing the Right Route
Route selection depends on multiple factors:
Treatment goals: Is the primary goal rapid symptom relief for severe depression? IV or IM might be appropriate. Is the goal deep psychological processing? IM with psychotherapy support may be ideal. Is the goal affordable maintenance? Sublingual could work well.
Patient factors: Has the patient had difficult psychedelic experiences before? IV offers more control. Is the patient highly sensitive to medications? Start gentler with sublingual or low-dose IV. Does the patient have medical conditions affecting certain routes?
Setting factors: What routes can your clinic safely administer? IM at higher doses requires resuscitation capacity. Sublingual can be administered in simpler settings.
Cost considerations: IV and IM sessions in clinical settings are typically more expensive than sublingual home programs, though insurance coverage varies.
What Patients Should Know
For those considering ketamine treatment:
It requires medical supervision. Ketamine should only be used under the care of licensed medical providers who can assess appropriateness, monitor for adverse effects, and adjust treatment as needed.
It's not a one-time fix. While some patients experience significant relief after a single session, most benefit from a series of treatments plus integration work. Maintenance may be needed long-term for some conditions.
Set and setting matter. The environment in which ketamine is administered affects the experience. Clinical settings with trained staff, comfortable surroundings, and appropriate therapeutic support optimize outcomes.
Integration is crucial. The window of neuroplasticity ketamine opens needs to be used—through therapy, lifestyle changes, and applying insights. Without integration, benefits may be temporary.
Key Takeaways
Ketamine works by promoting neuroplasticity and quieting rigid brain patterns, creating a window for therapeutic change
IV ketamine is most studied and allows dose adjustment during sessions; standard protocol is 6-8 infusions over 3-4 weeks
IM ketamine produces more intense experiences suited for deep psychotherapeutic work but requires appropriate safety measures
Sublingual ketamine is most accessible and lowest-risk, with milder experiences suitable for many applications
The "three-person relationship" between patient, therapist, and medical provider is essential
Route selection depends on treatment goals, patient factors, setting capabilities, and cost
Integration with psychotherapy appears to enhance outcomes beyond medical ketamine alone
References and Expert Sources
This article draws on presentations and research from:
Dr. Meghan Oxley, M.D. — Emergency medicine physician; Founder of Michigan Progressive Health; Board member of the American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3)
Dr. Sandhya Prashad, M.D. — Psychiatrist specializing in interventional psychiatry and IV ketamine; ASKP3 board member
Dr. Veronika Gold, Ph.D. — Ketamine-assisted psychotherapy practitioner and educator
American Society of Ketamine Physicians, Psychotherapists and Practitioners — Professional organization guidelines
This article is for educational purposes only and does not constitute medical advice. Ketamine should only be used under the supervision of licensed healthcare providers. If you are considering ketamine treatment, consult with a qualified medical professional to determine if it's appropriate for your situation.
